Global Age Related Macular Degeneration Drugs Market Insights and Forecast to 2031

Report ID: 1561134 | Published Date: Nov 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Age Related Macular Degeneration Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Lucentis
        1.2.3 Eylea
        1.2.4 Avastin
        1.2.5 Squalamine
        1.2.6 Conercept
        1.2.7 Lampalizamab
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 50-60 Years Old
        1.3.3 60-70 Years Old
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Age Related Macular Degeneration Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Age Related Macular Degeneration Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Age Related Macular Degeneration Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Age Related Macular Degeneration Drugs Sales by Region
        2.4.1 Global Age Related Macular Degeneration Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Age Related Macular Degeneration Drugs by Region (2023-2028)
    2.5 Global Age Related Macular Degeneration Drugs Revenue by Region
        2.5.1 Global Age Related Macular Degeneration Drugs Revenue by Region (2017-2022)
        2.5.2 Global Age Related Macular Degeneration Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Age Related Macular Degeneration Drugs Sales by Manufacturers
        3.1.1 Global Top Age Related Macular Degeneration Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Age Related Macular Degeneration Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Age Related Macular Degeneration Drugs in 2021
    3.2 Global Age Related Macular Degeneration Drugs Revenue by Manufacturers
        3.2.1 Global Age Related Macular Degeneration Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Age Related Macular Degeneration Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration Drugs Revenue in 2021
    3.3 Global Age Related Macular Degeneration Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Age Related Macular Degeneration Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Age Related Macular Degeneration Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Age Related Macular Degeneration Drugs Sales by Type
        4.1.1 Global Age Related Macular Degeneration Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Age Related Macular Degeneration Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Age Related Macular Degeneration Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Age Related Macular Degeneration Drugs Revenue by Type
        4.2.1 Global Age Related Macular Degeneration Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Age Related Macular Degeneration Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Age Related Macular Degeneration Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Age Related Macular Degeneration Drugs Price by Type
        4.3.1 Global Age Related Macular Degeneration Drugs Price by Type (2017-2022)
        4.3.2 Global Age Related Macular Degeneration Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Age Related Macular Degeneration Drugs Sales by Application
        5.1.1 Global Age Related Macular Degeneration Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Age Related Macular Degeneration Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Age Related Macular Degeneration Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Age Related Macular Degeneration Drugs Revenue by Application
        5.2.1 Global Age Related Macular Degeneration Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Age Related Macular Degeneration Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Age Related Macular Degeneration Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Age Related Macular Degeneration Drugs Price by Application
        5.3.1 Global Age Related Macular Degeneration Drugs Price by Application (2017-2022)
        5.3.2 Global Age Related Macular Degeneration Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Age Related Macular Degeneration Drugs Market Size by Type
        6.1.1 North America Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
        6.1.2 North America Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
    6.2 North America Age Related Macular Degeneration Drugs Market Size by Application
        6.2.1 North America Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
        6.2.2 North America Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
    6.3 North America Age Related Macular Degeneration Drugs Market Size by Country
        6.3.1 North America Age Related Macular Degeneration Drugs Sales by Country (2017-2028)
        6.3.2 North America Age Related Macular Degeneration Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Age Related Macular Degeneration Drugs Market Size by Type
        7.1.1 Europe Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
        7.1.2 Europe Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
    7.2 Europe Age Related Macular Degeneration Drugs Market Size by Application
        7.2.1 Europe Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
        7.2.2 Europe Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
    7.3 Europe Age Related Macular Degeneration Drugs Market Size by Country
        7.3.1 Europe Age Related Macular Degeneration Drugs Sales by Country (2017-2028)
        7.3.2 Europe Age Related Macular Degeneration Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Age Related Macular Degeneration Drugs Market Size by Type
        8.1.1 Asia Pacific Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Age Related Macular Degeneration Drugs Market Size by Application
        8.2.1 Asia Pacific Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Age Related Macular Degeneration Drugs Market Size by Region
        8.3.1 Asia Pacific Age Related Macular Degeneration Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Age Related Macular Degeneration Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Age Related Macular Degeneration Drugs Market Size by Type
        9.1.1 Latin America Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
    9.2 Latin America Age Related Macular Degeneration Drugs Market Size by Application
        9.2.1 Latin America Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
    9.3 Latin America Age Related Macular Degeneration Drugs Market Size by Country
        9.3.1 Latin America Age Related Macular Degeneration Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Age Related Macular Degeneration Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Age Related Macular Degeneration Drugs Market Size by Type
        10.1.1 Middle East and Africa Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Age Related Macular Degeneration Drugs Market Size by Application
        10.2.1 Middle East and Africa Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Age Related Macular Degeneration Drugs Market Size by Country
        10.3.1 Middle East and Africa Age Related Macular Degeneration Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novartis
        11.1.1 Novartis Corporation Information
        11.1.2 Novartis Overview
        11.1.3 Novartis Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novartis Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novartis Recent Developments
    11.2 Bayer Healthcare
        11.2.1 Bayer Healthcare Corporation Information
        11.2.2 Bayer Healthcare Overview
        11.2.3 Bayer Healthcare Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bayer Healthcare Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer Healthcare Recent Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Recent Developments
    11.4 Neurotech Pharmaceuticals
        11.4.1 Neurotech Pharmaceuticals Corporation Information
        11.4.2 Neurotech Pharmaceuticals Overview
        11.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Neurotech Pharmaceuticals Recent Developments
    11.5 Regeneron Pharmaceuticals
        11.5.1 Regeneron Pharmaceuticals Corporation Information
        11.5.2 Regeneron Pharmaceuticals Overview
        11.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Regeneron Pharmaceuticals Recent Developments
    11.6 Allergan
        11.6.1 Allergan Corporation Information
        11.6.2 Allergan Overview
        11.6.3 Allergan Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Allergan Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Allergan Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Age Related Macular Degeneration Drugs Industry Chain Analysis
    12.2 Age Related Macular Degeneration Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Age Related Macular Degeneration Drugs Production Mode & Process
    12.4 Age Related Macular Degeneration Drugs Sales and Marketing
        12.4.1 Age Related Macular Degeneration Drugs Sales Channels
        12.4.2 Age Related Macular Degeneration Drugs Distributors
    12.5 Age Related Macular Degeneration Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Age Related Macular Degeneration Drugs Industry Trends
    13.2 Age Related Macular Degeneration Drugs Market Drivers
    13.3 Age Related Macular Degeneration Drugs Market Challenges
    13.4 Age Related Macular Degeneration Drugs Market Restraints
14 Key Findings in The Global Age Related Macular Degeneration Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Lucentis
    Table 3. Major Manufacturers of Eylea
    Table 4. Major Manufacturers of Avastin
    Table 5. Major Manufacturers of Squalamine
    Table 6. Major Manufacturers of Conercept
    Table 7. Major Manufacturers of Lampalizamab
    Table 8. Major Manufacturers of Others
    Table 9. Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Age Related Macular Degeneration Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Age Related Macular Degeneration Drugs Sales by Region (2017-2022) & (K MT)
    Table 12. Global Age Related Macular Degeneration Drugs Sales Market Share by Region (2017-2022)
    Table 13. Global Age Related Macular Degeneration Drugs Sales by Region (2023-2028) & (K MT)
    Table 14. Global Age Related Macular Degeneration Drugs Sales Market Share by Region (2023-2028)
    Table 15. Global Age Related Macular Degeneration Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Age Related Macular Degeneration Drugs Revenue Market Share by Region (2017-2022)
    Table 17. Global Age Related Macular Degeneration Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Age Related Macular Degeneration Drugs Revenue Market Share by Region (2023-2028)
    Table 19. Global Age Related Macular Degeneration Drugs Sales by Manufacturers (2017-2022) & (K MT)
    Table 20. Global Age Related Macular Degeneration Drugs Sales Share by Manufacturers (2017-2022)
    Table 21. Global Age Related Macular Degeneration Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 22. Global Age Related Macular Degeneration Drugs Revenue Share by Manufacturers (2017-2022)
    Table 23. Age Related Macular Degeneration Drugs Price by Manufacturers (2017-2022) &(USD/MT)
    Table 24. Global Age Related Macular Degeneration Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Age Related Macular Degeneration Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drugs as of 2021)
    Table 26. Age Related Macular Degeneration Drugs Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Age Related Macular Degeneration Drugs Product Offered
    Table 28. Date of Manufacturers Enter into Age Related Macular Degeneration Drugs Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Age Related Macular Degeneration Drugs Sales by Type (2017-2022) & (K MT)
    Table 31. Global Age Related Macular Degeneration Drugs Sales by Type (2023-2028) & (K MT)
    Table 32. Global Age Related Macular Degeneration Drugs Sales Share by Type (2017-2022)
    Table 33. Global Age Related Macular Degeneration Drugs Sales Share by Type (2023-2028)
    Table 34. Global Age Related Macular Degeneration Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 35. Global Age Related Macular Degeneration Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 36. Global Age Related Macular Degeneration Drugs Revenue Share by Type (2017-2022)
    Table 37. Global Age Related Macular Degeneration Drugs Revenue Share by Type (2023-2028)
    Table 38. Age Related Macular Degeneration Drugs Price by Type (2017-2022) & (USD/MT)
    Table 39. Global Age Related Macular Degeneration Drugs Price Forecast by Type (2023-2028) & (USD/MT)
    Table 40. Global Age Related Macular Degeneration Drugs Sales by Application (2017-2022) & (K MT)
    Table 41. Global Age Related Macular Degeneration Drugs Sales by Application (2023-2028) & (K MT)
    Table 42. Global Age Related Macular Degeneration Drugs Sales Share by Application (2017-2022)
    Table 43. Global Age Related Macular Degeneration Drugs Sales Share by Application (2023-2028)
    Table 44. Global Age Related Macular Degeneration Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 45. Global Age Related Macular Degeneration Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 46. Global Age Related Macular Degeneration Drugs Revenue Share by Application (2017-2022)
    Table 47. Global Age Related Macular Degeneration Drugs Revenue Share by Application (2023-2028)
    Table 48. Age Related Macular Degeneration Drugs Price by Application (2017-2022) & (USD/MT)
    Table 49. Global Age Related Macular Degeneration Drugs Price Forecast by Application (2023-2028) & (USD/MT)
    Table 50. North America Age Related Macular Degeneration Drugs Sales by Type (2017-2022) & (K MT)
    Table 51. North America Age Related Macular Degeneration Drugs Sales by Type (2023-2028) & (K MT)
    Table 52. North America Age Related Macular Degeneration Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 53. North America Age Related Macular Degeneration Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 54. North America Age Related Macular Degeneration Drugs Sales by Application (2017-2022) & (K MT)
    Table 55. North America Age Related Macular Degeneration Drugs Sales by Application (2023-2028) & (K MT)
    Table 56. North America Age Related Macular Degeneration Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 57. North America Age Related Macular Degeneration Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 58. North America Age Related Macular Degeneration Drugs Sales by Country (2017-2022) & (K MT)
    Table 59. North America Age Related Macular Degeneration Drugs Sales by Country (2023-2028) & (K MT)
    Table 60. North America Age Related Macular Degeneration Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 61. North America Age Related Macular Degeneration Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 62. Europe Age Related Macular Degeneration Drugs Sales by Type (2017-2022) & (K MT)
    Table 63. Europe Age Related Macular Degeneration Drugs Sales by Type (2023-2028) & (K MT)
    Table 64. Europe Age Related Macular Degeneration Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 65. Europe Age Related Macular Degeneration Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 66. Europe Age Related Macular Degeneration Drugs Sales by Application (2017-2022) & (K MT)
    Table 67. Europe Age Related Macular Degeneration Drugs Sales by Application (2023-2028) & (K MT)
    Table 68. Europe Age Related Macular Degeneration Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 69. Europe Age Related Macular Degeneration Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 70. Europe Age Related Macular Degeneration Drugs Sales by Country (2017-2022) & (K MT)
    Table 71. Europe Age Related Macular Degeneration Drugs Sales by Country (2023-2028) & (K MT)
    Table 72. Europe Age Related Macular Degeneration Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 73. Europe Age Related Macular Degeneration Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Age Related Macular Degeneration Drugs Sales by Type (2017-2022) & (K MT)
    Table 75. Asia Pacific Age Related Macular Degeneration Drugs Sales by Type (2023-2028) & (K MT)
    Table 76. Asia Pacific Age Related Macular Degeneration Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Age Related Macular Degeneration Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Age Related Macular Degeneration Drugs Sales by Application (2017-2022) & (K MT)
    Table 79. Asia Pacific Age Related Macular Degeneration Drugs Sales by Application (2023-2028) & (K MT)
    Table 80. Asia Pacific Age Related Macular Degeneration Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Age Related Macular Degeneration Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Age Related Macular Degeneration Drugs Sales by Region (2017-2022) & (K MT)
    Table 83. Asia Pacific Age Related Macular Degeneration Drugs Sales by Region (2023-2028) & (K MT)
    Table 84. Asia Pacific Age Related Macular Degeneration Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Age Related Macular Degeneration Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 86. Latin America Age Related Macular Degeneration Drugs Sales by Type (2017-2022) & (K MT)
    Table 87. Latin America Age Related Macular Degeneration Drugs Sales by Type (2023-2028) & (K MT)
    Table 88. Latin America Age Related Macular Degeneration Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 89. Latin America Age Related Macular Degeneration Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 90. Latin America Age Related Macular Degeneration Drugs Sales by Application (2017-2022) & (K MT)
    Table 91. Latin America Age Related Macular Degeneration Drugs Sales by Application (2023-2028) & (K MT)
    Table 92. Latin America Age Related Macular Degeneration Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 93. Latin America Age Related Macular Degeneration Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 94. Latin America Age Related Macular Degeneration Drugs Sales by Country (2017-2022) & (K MT)
    Table 95. Latin America Age Related Macular Degeneration Drugs Sales by Country (2023-2028) & (K MT)
    Table 96. Latin America Age Related Macular Degeneration Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 97. Latin America Age Related Macular Degeneration Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Age Related Macular Degeneration Drugs Sales by Type (2017-2022) & (K MT)
    Table 99. Middle East and Africa Age Related Macular Degeneration Drugs Sales by Type (2023-2028) & (K MT)
    Table 100. Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Age Related Macular Degeneration Drugs Sales by Application (2017-2022) & (K MT)
    Table 103. Middle East and Africa Age Related Macular Degeneration Drugs Sales by Application (2023-2028) & (K MT)
    Table 104. Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Age Related Macular Degeneration Drugs Sales by Country (2017-2022) & (K MT)
    Table 107. Middle East and Africa Age Related Macular Degeneration Drugs Sales by Country (2023-2028) & (K MT)
    Table 108. Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 110. Novartis Corporation Information
    Table 111. Novartis Description and Major Businesses
    Table 112. Novartis Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 113. Novartis Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Novartis Recent Developments
    Table 115. Bayer Healthcare Corporation Information
    Table 116. Bayer Healthcare Description and Major Businesses
    Table 117. Bayer Healthcare Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 118. Bayer Healthcare Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Bayer Healthcare Recent Developments
    Table 120. Roche Corporation Information
    Table 121. Roche Description and Major Businesses
    Table 122. Roche Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 123. Roche Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Roche Recent Developments
    Table 125. Neurotech Pharmaceuticals Corporation Information
    Table 126. Neurotech Pharmaceuticals Description and Major Businesses
    Table 127. Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 128. Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Neurotech Pharmaceuticals Recent Developments
    Table 130. Regeneron Pharmaceuticals Corporation Information
    Table 131. Regeneron Pharmaceuticals Description and Major Businesses
    Table 132. Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 133. Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Regeneron Pharmaceuticals Recent Developments
    Table 135. Allergan Corporation Information
    Table 136. Allergan Description and Major Businesses
    Table 137. Allergan Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 138. Allergan Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Allergan Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Age Related Macular Degeneration Drugs Distributors List
    Table 143. Age Related Macular Degeneration Drugs Customers List
    Table 144. Age Related Macular Degeneration Drugs Market Trends
    Table 145. Age Related Macular Degeneration Drugs Market Drivers
    Table 146. Age Related Macular Degeneration Drugs Market Challenges
    Table 147. Age Related Macular Degeneration Drugs Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Age Related Macular Degeneration Drugs Product Picture
    Figure 3. Global Age Related Macular Degeneration Drugs Market Share by Type in 2021 & 2028
    Figure 3. Lucentis Product Picture
    Figure 4. Eylea Product Picture
    Figure 5. Avastin Product Picture
    Figure 6. Squalamine Product Picture
    Figure 7. Conercept Product Picture
    Figure 8. Lampalizamab Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Age Related Macular Degeneration Drugs Market Share by Application in 2021 & 2028
    Figure 11. 50-60 Years Old
    Figure 12. 60-70 Years Old
    Figure 13. Others
    Figure 14. Age Related Macular Degeneration Drugs Report Years Considered
    Figure 15. Global Age Related Macular Degeneration Drugs Sales 2017-2028 (K MT)
    Figure 16. Global Age Related Macular Degeneration Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Age Related Macular Degeneration Drugs Revenue 2017-2028 (US$ Million)
    Figure 18. Global Age Related Macular Degeneration Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Age Related Macular Degeneration Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Age Related Macular Degeneration Drugs Sales Market Share by Region (2023-2028)
    Figure 21. North America Age Related Macular Degeneration Drugs Sales YoY (2017-2028) & (K MT)
    Figure 22. North America Age Related Macular Degeneration Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Age Related Macular Degeneration Drugs Sales YoY (2017-2028) & (K MT)
    Figure 24. Europe Age Related Macular Degeneration Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Age Related Macular Degeneration Drugs Sales YoY (2017-2028) & (K MT)
    Figure 26. Asia-Pacific Age Related Macular Degeneration Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Age Related Macular Degeneration Drugs Sales YoY (2017-2028) & (K MT)
    Figure 28. Latin America Age Related Macular Degeneration Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Age Related Macular Degeneration Drugs Sales YoY (2017-2028) & (K MT)
    Figure 30. Middle East & Africa Age Related Macular Degeneration Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Age Related Macular Degeneration Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Age Related Macular Degeneration Drugs in the World: Market Share by Age Related Macular Degeneration Drugs Revenue in 2021
    Figure 33. Global Age Related Macular Degeneration Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Age Related Macular Degeneration Drugs Sales Market Share by Type (2017-2028)
    Figure 35. Global Age Related Macular Degeneration Drugs Revenue Market Share by Type (2017-2028)
    Figure 36. Global Age Related Macular Degeneration Drugs Sales Market Share by Application (2017-2028)
    Figure 37. Global Age Related Macular Degeneration Drugs Revenue Market Share by Application (2017-2028)
    Figure 38. North America Age Related Macular Degeneration Drugs Sales Market Share by Type (2017-2028)
    Figure 39. North America Age Related Macular Degeneration Drugs Revenue Market Share by Type (2017-2028)
    Figure 40. North America Age Related Macular Degeneration Drugs Sales Market Share by Application (2017-2028)
    Figure 41. North America Age Related Macular Degeneration Drugs Revenue Market Share by Application (2017-2028)
    Figure 42. North America Age Related Macular Degeneration Drugs Sales Share by Country (2017-2028)
    Figure 43. North America Age Related Macular Degeneration Drugs Revenue Share by Country (2017-2028)
    Figure 44. U.S. Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Age Related Macular Degeneration Drugs Sales Market Share by Type (2017-2028)
    Figure 47. Europe Age Related Macular Degeneration Drugs Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Age Related Macular Degeneration Drugs Sales Market Share by Application (2017-2028)
    Figure 49. Europe Age Related Macular Degeneration Drugs Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Age Related Macular Degeneration Drugs Sales Share by Country (2017-2028)
    Figure 51. Europe Age Related Macular Degeneration Drugs Revenue Share by Country (2017-2028)
    Figure 52. Germany Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. France Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Age Related Macular Degeneration Drugs Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Age Related Macular Degeneration Drugs Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Age Related Macular Degeneration Drugs Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Age Related Macular Degeneration Drugs Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Age Related Macular Degeneration Drugs Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Age Related Macular Degeneration Drugs Revenue Share by Region (2017-2028)
    Figure 63. China Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. India Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Age Related Macular Degeneration Drugs Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Age Related Macular Degeneration Drugs Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Age Related Macular Degeneration Drugs Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Age Related Macular Degeneration Drugs Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Age Related Macular Degeneration Drugs Sales Share by Country (2017-2028)
    Figure 78. Latin America Age Related Macular Degeneration Drugs Revenue Share by Country (2017-2028)
    Figure 79. Mexico Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Age Related Macular Degeneration Drugs Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Age Related Macular Degeneration Drugs Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Age Related Macular Degeneration Drugs Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Age Related Macular Degeneration Drugs Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Age Related Macular Degeneration Drugs Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Age Related Macular Degeneration Drugs Revenue Share by Country (2017-2028)
    Figure 88. Turkey Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Age Related Macular Degeneration Drugs Revenue (2017-2028) & (US$ Million)
    Figure 91. Age Related Macular Degeneration Drugs Value Chain
    Figure 92. Age Related Macular Degeneration Drugs Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
Frequently Asked Questions
Age Related Macular Degeneration Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Age Related Macular Degeneration Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Age Related Macular Degeneration Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Magnesium Lactate

Magnesium Lactate market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Magnesium Silicate

Magnesium Silicate market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More